Showing results (21-30 of 368) with videos related to
Sort By:
Pageof 37
Schizophrenia Research|September 15, 2016
Antipsychotic long-acting injections: A community-based study from 2007 to 2014 of prescribing trends and characteristics associated with initiationHélène Verdoux, Elodie Pambrun, Marie Tournier, et al.Fundamental & Clinical Pharmacology|January 6, 2022
Antihypertensive and lipid-lowering drugs usage after primary stroke in a large representative sample of the French populationJulia Perrier, Valérie Olié, Amélie Gabet, et al.Journal of the American Geriatrics Society|September 25, 2018
Risk of Serious Trauma with Glucose-Lowering Drugs in Older Persons: A Nested Case-Control StudyMickael Arnaud, Antoine Pariente, Julien Bezin, et al.Expert Review of Pharmacoeconomics & Outcomes Research|September 16, 2021
Prevalence and direct costs of potentially inappropriate prescriptions in France: a population-based studyBarbara Roux, Julien Bezin, Camille Morival, et al.Clinical Pharmacology and Therapeutics|July 12, 2018
Use of Lipid-Lowering Drugs and the Risk of Cataract: A Population-Based Nested Case-Control StudyJulien Bezin, Yohann Mansiaux, Pernelle Noize, et al.BMJ Open|December 16, 2025
Effectiveness of antihypertensive drugs for secondary prevention of ischaemic stroke: a nationwide historic cohort studyJulia Perrier, Amelie Gabet, Valérie Olié, et al.Pharmacoepidemiology and Drug Safety|July 3, 2022
Potentially inappropriate medication use by level of polypharmacy among US Veterans 49-64 and 65-70 years oldJordan Guillot, Christopher T Rentsch, Kirsha S Gordon, et al.Journal of Clinical Medicine|November 25, 2020
The Burden of Potentially Inappropriate Medications in Chronic PolypharmacyJordan Guillot, Sandy Maumus-Robert, Alexandre Marceron, et al.BMJ (Clinical Research Ed.)|March 24, 2022
Risk of first ischaemic stroke and use of antidopaminergic antiemetics: nationwide case-time-control studyAnne Bénard-Laribière, Emilie Hucteau, Stéphanie Debette, et al.Fundamental & Clinical Pharmacology|February 23, 2026
SGLT-2 Inhibitors Use in Hospitalized Patients in France: A Cross-Sectional StudyMaxime Demourgues, Julien Bezin, Romain Griffier, et al.Pageof 37